Rating: AVOID (Speculative-Only)
| Metric | Value |
|---|---|
| Current Price | $226.72 |
| Target Price (Scenario PWEV) | $240.00 |
| PWEV | $240.00 |
| Upside to PWEV | +6% |
| Market Cap | $50.1B |
| EV / Revenue | ~95x |
| Bear Case (30% prob) | $79 (−65%) |
| Bull Case (10% prob) | $676 (+198%) |
Methodology note: The standard earnings × P/E engine does not apply to Cerebras. The company has negative EBITDA (−$111M), a −30.6% operating margin, and no meaningful P/E. This analysis uses a revenue-multiple scenario framework (FY28E revenue × exit EV/Revenue), the correct tool for a pre-profit hyper-growth name. The output is deliberately a distribution, not a point estimate — because the outcome genuinely is binary.
Investment Thesis (Bull Case, Taken Seriously)
Cerebras Systems is the most differentiated non-GPU bet in AI compute. The Wafer-Scale Engine — a single dinner-plate-sized chip that sidesteps the GPU interconnect bottleneck — posts inference-latency numbers Nvidia cannot match. This is real engineering, not a TAM slide. The company carries a $24.6 billion backlog, roughly 48x its FY25 revenue of $510M — the single hardest data point supporting an otherwise extreme valuation, because it represents contracted demand rather than aspiration.
Crucially, the marquee deals finally diversify away from Abu Dhabi: a multi-year OpenAI agreement (750MW, valued at more than $20B) and an AWS inference partnership are exactly the blue-chip, non-UAE customers the bear case demands. If these convert, the concentration problem dissolves and the customer roster becomes best-in-class. With AI shifting from training to inference-at-scale — where latency and cost-per-token dominate raw FLOPs — Cerebras is purpose-built for the fastest-growing segment of compute, and hyperscaler hunger for Nvidia alternatives gives its scarce architecture strategic and acquisition value.
Anti-Thesis (The Real Bear Case)
The valuation prices flawless execution for years. At 95x EV/revenue, the market is discounting **$3.7B of FY28 revenue — 7x FY25 in three years, a 94%/yr CAGR — while sustaining a 12x revenue multiple.** Both must happen, or the downside is brutal (the bear scenario is −65%).
The concentration is the killer. The headline "G42 fell from 85% of revenue (2024) to 24% (2025)" sounds like de-risking — but it isn't. The concentration simply moved to another Abu Dhabi entity, MBZUAI, now 62% of 2025 revenue. Combined UAE-linked revenue is still ~86%. This is geopolitical, related-party, single-region concentration of the most extreme kind; one CFIUS action or UAE budget decision puts the majority of revenue at risk.
Meanwhile, Nvidia, AMD, Google TPU, Amazon Trainium/Inferentia and Groq offer more proven, more diversified, more defensible compute at a fraction of Cerebras's multiple. The company loses money (negative EBITDA, −30.6% operating margin, negative book equity). And a calendar-certain November 2026 lockup expiry will roughly 6x the public float (34.5M → ~221M shares) as insiders and pre-IPO holders become free to sell — recently-IPO'd names with concentrated pre-IPO ownership routinely fall 20–40% through lockup.
Key Debate
Do the OpenAI + AWS deals convert into enough non-UAE revenue, fast enough, to justify ~95x revenue — before the multiple compresses or the lockup floods the float? It is a race between three clocks: the revenue clock (backlog → recognized revenue, bull), the multiple clock (hyper-growth premium → normalization as it scales, bear), and the float clock (November lockup → supply overhang, bear and calendar-certain). The bull needs the revenue clock to win decisively before November. The bear only needs one of the other two clocks to ring.
Scenario Valuation
The dispersion is the finding — an 8.5x spread from bear to mega-bull.
| Scenario | Prob | FY28E Rev | Exit EV/Rev | Price | Return |
|---|---|---|---|---|---|
| Concentration Bites / Competition | 30% | $1.5B | 8x | $79 | −65% |
| Backlog Converts Slowly | 20% | $2.5B | 10x | $138 | −39% |
| Base — Steady Conversion | 25% | $4.0B | 12x | $242 | +7% |
| Bull — Inference Scale | 15% | $6.0B | 14x | $405 | +79% |
| Mega Bull — Wafer-scale Wins | 10% | $9.0B | 16x | $676 | +198% |
| PWEV | — | — | — | $240 | +6% |
The PWEV (+6%) is almost meaningless against an 8.5x outcome dispersion. This is a coin-flip binary where expected value roughly equals the current price — you are not paid a positive expected return for taking enormous binary risk, and the near-term skew (lockup) is to the downside.
Load-Bearing Assumptions
- OpenAI's 750MW deal converts to recognized revenue at healthy margins (not a slow, thin-margin capacity reservation).
- MBZUAI/G42 revenue does not collapse — 86% of the base depends on continued Abu Dhabi spending and no CFIUS/geopolitical disruption.
- The market keeps paying ≥12x revenue as Cerebras scales (historically, hyper-growth multiples compress).
- Cerebras reaches profitability before capital markets turn.
- The November lockup is absorbed without a cascade.
Reasons the Thesis Could Fail (Falsifiable)
- November lockup expiry triggers a >25% drawdown (calendar-certain test).
- Any quarter where MBZUAI/G42 revenue declines sequentially.
- OpenAI/AWS terms disclosed as capacity-reservation rather than committed revenue, or margin-dilutive.
- Nvidia/AMD/Groq win a marquee inference customer Cerebras was targeting.
- Gross margin fails to expand toward 50%+ (proof the model cannot be profitable).
- A secondary offering or insider selling disclosed post-lockup.
- The multiple compresses below 10x revenue on any growth wobble.
Fact / Inference / Speculation
- FACT: $50B market cap on $510M revenue, ~95x EV/Rev, negative EBITDA, $24.6B backlog, 86% Abu Dhabi-linked revenue (2025), OpenAI 750MW/>$20B and AWS deals exist, IPO'd May 13 2026 at $185, lockup expires ~Nov 2026.
- INFERENCE: Market prices ~$3.7B FY28 revenue (94%/yr CAGR) at a sustained 12x. PWEV ~$240 with an 8.5x bear-to-bull dispersion.
- SPECULATION: That OpenAI/AWS convert fast and at-margin; that Abu Dhabi revenue holds; that wafer-scale wins durable inference share against Nvidia; that the multiple survives scaling; that the lockup is absorbed cleanly.
Recommendation: AVOID / Speculative-Only
Why AVOID for a skeptical institutional mandate: ~95x revenue prices flawless execution; the +6% PWEV does not compensate for an 8.5x dispersion with a −65% left tail; 86% Abu Dhabi-linked concentration is an extreme single-point-of-failure; a calendar-certain November lockup will 6x the float; and Nvidia/AMD offer proven, profitable, diversified AI-compute exposure at a fraction of the multiple.
Why not an outright SHORT: the backlog and OpenAI/AWS deals are real — a single positive conversion headline could spike the stock 30%+ on the thin float; borrow on a recent IPO is expensive and recall-prone; and the mega-bull tail (+198%) is real if wafer-scale wins inference.
How to act: Do not initiate at $227 — this is a venture-style binary, not an institutional holding. If owned speculatively, size it as a venture lottery ticket (≤0.5% of portfolio) and wait for the November lockup, which is likely to offer a better entry (the $138–$185 zone). If holding from the IPO, trim aggressively into any strength before November. The cleanest expression of the AI-inference thesis with a fraction of the risk is NVDA/AVGO/AMD.
Kill criteria (revisit as a BUY): post-lockup, if (a) OpenAI/AWS revenue diversifies the mix below 50% UAE, (b) the multiple compresses to <15x forward revenue, and (c) a path to profitability is visible — the risk/reward could become attractive in the $130–180 range. None of those are true today.
The discipline here is to admire the technology and decline the stock. CBRS is not in the MCH 23-ticker portfolio and, on this analysis, should not be added.
Disclaimer: MCH Advisory research. Skeptical institutional framework. Not investment advice. Figures reconciled to Alpha Vantage data as of 24 June 2026. The earnings × P/E engine was deliberately not used (pre-profit); valuation is scenario-based.